China approves Pfizer GLP-1 drug for weight loss

By Andrew Silver SHANGHAI, March 6 (Reuters) - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight ...
AASTOCKS.com

Pfizer's Weight Loss Injection GLP-1 Ecnoglutide Injection Approved in CN

Pfizer China announced that the National Medical Products Administration (NMPA) has officially approved the new-generation ...

China Clears Weight-Loss Shot As Pfizer Enters Crowded Market

China's National Medical Products Administration has approved Pfizer Inc.’s PFE ecnoglutide injection for chronic weight management in adults with overweight or obesity, marking the first approval of ...
AOL

Pfizer CEO Albert Bourla says aggressive bid for Metsera reflects company's 'right to win' obesity market

Pfizer (PFE) CEO and chairman Albert Bourla told Yahoo Finance Executive Editor Brian Sozzi during Yahoo Finance's annual Investconference that the $10 billion acquisition of GLP-1 maker Metsera (MTSR ...

1 Reason I'd Happily Buy Pfizer (PFE) Stock and Never Sell

The reason is so compelling that I actually did buy the stock -- and I have no plans to sell.

China approves Pfizer GLP-1 drug for weight management

SHANGHAI, March 6 () - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management ‌in overweight ...